In 2023, the import value of cortisone, hydrocortisone, prednisone, and prednisolone to Brazil stood at approximately 19 million USD. The forecast from 2024 to 2028 shows a steady year-on-year increase in value, projecting a rise to nearly 23 million USD by 2028. The year-on-year growth rates from one year to the next are forecasted to be just under 4% on average, which suggests continued strong demand or possible price increases for these pharmaceutical products.
Future trends to watch include:
- Potential shifts in local production capacity, which could influence import reliance.
- Regulatory changes affecting pharmaceutical imports in Brazil.
- Global supply chain dynamics, particularly in light of geopolitical or economic disturbances.
- Evolving healthcare needs or treatment paradigms impacting corticosteroid demand.
